Key Events This Week
09 Feb: Stock surges 6.58% on strong volume
10 Feb: Q3 FY26 results reveal profit surge
11 Feb: Mixed annual performance reported; stock dips 5.93%
12 Feb: Technical and financial trends improve; stock rallies 7.60%
13 Feb: MarketsMOJO upgrades rating to Sell; stock closes at ₹136.70
09 February 2026: Strong Opening Rally
Makers Laboratories began the week on a robust note, surging 6.58% to close at ₹137.65 on 9 February, supported by a volume of 17,032 shares. This sharp gain outpaced the Sensex’s 1.04% rise, signalling early investor enthusiasm. The rally was likely driven by anticipation of the company’s upcoming quarterly results and renewed interest in the stock after a period of relative stagnation.
10 February 2026: Quarterly Profit Surge Revealed
The company released its Q3 FY26 results on 10 February, reporting a significant profit surge that masked deeper structural concerns. Net sales reached ₹35.67 crores, the highest quarterly revenue in recent history, while EBITDA rose to ₹4.16 crores, reflecting improved operational efficiency. The operating profit margin expanded to 11.66%, a notable improvement signalling better cost management. The stock responded positively, gaining 4.14% to close at ₹143.35, further outperforming the Sensex’s modest 0.25% increase.
11 February 2026: Mixed Annual Performance and Profitability Challenges
Despite the strong quarterly performance, the company disclosed a steep 84.86% decline in nine-month PAT to ₹1.26 crores, highlighting ongoing challenges in sustaining consistent earnings growth. This mixed annual performance weighed on sentiment, with the stock retreating 5.93% to ₹134.85 amid lower volume of 7,853 shares. The Sensex continued its modest upward trend, gaining 0.13%, underscoring the stock’s relative weakness on the day.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
12 February 2026: Technical and Financial Trends Improve
The stock rebounded sharply on 12 February, climbing 7.60% to ₹145.10 on strong volume of 28,010 shares. This rally coincided with reports of stabilising technical indicators and an improving financial trend, as the company’s quarterly results gained wider recognition. Despite the Sensex declining 0.56%, Makers Laboratories demonstrated resilience, supported by bullish weekly and monthly technical signals such as MACD and Bollinger Bands. This day marked the highest closing price of the week, reflecting renewed investor confidence.
13 February 2026: Upgrade to Sell Rating and Week Close
On the final trading day of the week, Makers Laboratories was upgraded by MarketsMOJO from a ‘Strong Sell’ to a ‘Sell’ rating, reflecting cautious optimism amid improving financial and technical trends. The upgrade acknowledged the company’s highest-ever quarterly net sales and margin expansion, though it also highlighted lingering valuation concerns and weak long-term fundamentals. The stock closed at ₹136.70, down 5.79% on the day but still ending the week with a 5.85% gain overall. The Sensex fell 1.40%, underscoring the stock’s relative outperformance despite the day’s pullback.
Considering Makers Laboratories Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.137.65 | +6.58% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.143.35 | +4.14% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.134.85 | -5.93% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.145.10 | +7.60% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.136.70 | -5.79% | 36,532.48 | -1.40% |
Key Takeaways
Positive Signals: Makers Laboratories demonstrated a strong quarterly turnaround with record net sales of ₹35.67 crores and an expanded operating margin of 11.66%. The company’s EBITDA and PAT for the quarter reached highs of ₹4.16 crores and ₹0.94 crores respectively, signalling improved operational efficiency and profitability. The upgrade from ‘Strong Sell’ to ‘Sell’ by MarketsMOJO reflects stabilising technical trends and cautious optimism about the company’s near-term prospects. The stock outperformed the Sensex by a wide margin, gaining 5.85% while the benchmark declined 0.54% over the week.
Cautionary Signals: Despite the quarterly gains, the nine-month PAT contracted sharply by 84.86%, underscoring persistent challenges in sustaining consistent earnings growth. The company’s valuation remains elevated relative to its modest return on equity of 2.20%, and its long-term operating profit CAGR is negative at -15.78%. Technical indicators show mixed momentum, with daily moving averages still mildly bearish. The stock’s recent volatility and underperformance over longer timeframes highlight ongoing structural concerns.
Conclusion
Makers Laboratories Ltd’s week was characterised by a notable rebound in quarterly financial performance and a corresponding upgrade in investment rating, which helped the stock outperform the broader market. The company’s highest-ever quarterly revenue and margin expansion provide a foundation for cautious optimism. However, the steep decline in nine-month profitability and weak long-term fundamentals temper enthusiasm. Investors should monitor upcoming quarterly results and technical signals closely to assess whether the recent momentum can be sustained amid sector challenges and valuation concerns. Overall, the week’s developments mark a tentative step forward for Makers Laboratories, balancing improved operational metrics against persistent structural headwinds.
Unlock special upgrade rates for a limited period. Start Saving Now →
